Rewind Therapeutics Belgium United Kingdom United States of America

Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy

Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan are world-renowned experts in neuroimaging, multiple sclerosis (MS) biomarkers, neuroimmunology, and translational drug developmentAppointments strengthen Rewind's clinical experience as its GPR17 remyelination therapy advances toward clinical trialsView original content:https://www.prnewswire.co.uk/news-releases/rewind-therapeutics-strengthens-scientific-advisory-board-with-leading-international-neurology-experts-as-it-advances-first-in-class-remyelination-therapy-302484390.html